BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 16516668)

  • 1. Biological insights into the pathogenesis of cutaneous T-cell lymphomas (CTCL).
    Whittaker S
    Semin Oncol; 2006 Feb; 33(1 Suppl 3):S3-6. PubMed ID: 16516668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma.
    Whittaker SJ; Foss FM
    Cancer Treat Rev; 2007 Apr; 33(2):146-60. PubMed ID: 17275192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human herpesvirus 7 detection by quantitative real time polymerase chain reaction in primary cutaneous T-cell lymphomas and healthy subjects: lack of a pathogenic role.
    Ponti R; Bergallo M; Costa C; Quaglino P; Fierro MT; Comessatti A; Stroppiana E; Sidoti F; Merlino C; Novelli M; Alotto D; Cavallo R; Bernengo MG
    Br J Dermatol; 2008 Nov; 159(5):1131-7. PubMed ID: 18782321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approach to lymphoproliferative infiltrates of the skin. The difficult lesions.
    Kempf W; Dummer R; Burg G
    Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S84-93. PubMed ID: 9894473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous T cell lymphoma-mycosis fungoides and Sezary syndrome: an update.
    Parker SR; Bethaney JV
    G Ital Dermatol Venereol; 2009 Aug; 144(4):467-85. PubMed ID: 19755952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
    Vidulich KA; Talpur R; Bassett RL; Duvic M
    Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
    Paulli M; Berti E
    Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
    Slater DN
    Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on treatment of cutaneous T-cell lymphoma.
    Gardner JM; Evans KG; Musiek A; Rook AH; Kim EJ
    Curr Opin Oncol; 2009 Mar; 21(2):131-7. PubMed ID: 19532014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocosis fungoides--an update on a non-mycotic disease.
    Makdisi J; Friedman A
    J Drugs Dermatol; 2013 Jul; 12(7):825-31. PubMed ID: 23884501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycosis fungoides: pathophysiology and emerging therapies.
    Duvic M; Foss FM
    Semin Oncol; 2007 Dec; 34(6 Suppl 5):S21-8. PubMed ID: 18086343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and clinical manifestations of cutaneous T-cell lymphoma.
    Koh HK; Charif M; Weinstock MA
    Hematol Oncol Clin North Am; 1995 Oct; 9(5):943-60. PubMed ID: 8522490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of cutaneous lymphoma.
    Abd-el-Baki J; Stefanato CM; Koh HK; Demierre MF; Foss FM
    Oncology (Williston Park); 1998 Oct; 12(10):1521-30; discussion 1532-4. PubMed ID: 9798206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential CCR4 expression and function in cutaneous T-cell lymphoma cell lines.
    Wu CS; Wang ST; Liao CY; Wu MT
    Kaohsiung J Med Sci; 2008 Nov; 24(11):577-90. PubMed ID: 19239991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathogenesis and therapy of cutaneous T cell lymphoma.
    Kim EJ; Hess S; Richardson SK; Newton S; Showe LC; Benoit BM; Ubriani R; Vittorio CC; Junkins-Hopkins JM; Wysocka M; Rook AH
    J Clin Invest; 2005 Apr; 115(4):798-812. PubMed ID: 15841167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous T-cell lymphomas: a review with emphasis on new treatment approaches.
    Querfeld C; Rosen ST; Kuzel TM; Guitart J
    Semin Cutan Med Surg; 2003 Sep; 22(3):150-61. PubMed ID: 14649582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transplant cutaneous T-cell lymphomas.
    Lok C; Viseux V; Denoeux JP; Bagot M
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):137-45. PubMed ID: 16046144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
    Magro CM; Dyrsen ME
    J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cutaneous T-cell lymphoma occurring after organ transplantation.
    Ravat FE; Spittle MF; Russell-Jones R
    J Am Acad Dermatol; 2006 Apr; 54(4):668-75. PubMed ID: 16546591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a role for epigenetic factors in the pathogenesis of epidermotropic cutaneous T-cell lymphomas (mycosis fungoides and Sézary syndrome)?
    Bachelez H
    Hematol J; 2001; 2(4):286-9. PubMed ID: 11920262
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.